The Impact of Pulmonary Disorders on Neurological Health (Lung-Brain Axis)

키워드

참고문헌 (184)

1. Cipolla MJ, "The Cerebral Circulation" (2009), Morgan & Claypool Life Sciences
2. Ogoh S, "Interaction between the respiratory system and cerebral blood flow regulation", J Appl Physiol, 127, pp.1197~1205 (2019)
3. Mergenthaler P, "Sugar for the brain : the role of glucose in physiological and pathological brain function", Trends Neurosci, 36, pp.587~597 (2013)
4. Sethi D, "Anatomy, Head and Neck: Carotid Arteries" (2023), StatPearls Publishing
5. Cummins EP, "Mechanisms and consequences of oxygen and carbon dioxide sensing in mammals", Physiol Rev, 100, pp.463~488 (2020)
6. Murphy PB, "Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation : a randomized clinical trial", JAMA, 317, pp.2177~2186 (2017)
7. Laffey JG, "Carbon dioxide and the critically ill--too little of a good thing?", Lancet, 354, pp.1283~1286 (1999)
8. Nattie E, "Central chemoreceptors : locations and functions", Compr Physiol, 2, pp.221~254 (2012)
9. Hattori T, "DNA ploidy patterns of minute carcinomas in the stomach", Jpn J Cancer Res, 77, pp.276~281 (1986)
10. Rummel C, "1st european psychoneuroimmunology network(epn)autumn school : Lung-brain axis in health and disease", Neuroimmunomodulation, 29(Suppl 2), pp.3~8 (2022)
11. Aghasafari P, "A review of inflammatory mechanism in airway diseases", Inflamm Res, 68, pp.59~74 (2019)
12. Sonar SA, "Blood-brain barrier and its function during inflammation and autoimmunity", J Leukoc Biol, 103, pp.839~853 (2018)
13. Mapunda JA, "How does the immune system enter the brain?", Front Immunol, 13, pp.805657~ (2022)
14. Luster AD, "Immune cell migration in inflammation : present and future therapeutic targets", Nat Immunol, 6, pp.1182~1190 (2005)
15. Chen J, "The lung microbiome : a new frontier for lung and brain disease", Int J Mol Sci, 24, pp.2170~ (2023)
16. Yagi K, "The lung microbiome during health and disease", Int J Mol Sci, 22, pp.10872~ (2021)
17. Charlson ES, "Topographical continuity of bacterial populations in the healthy human respiratory tract", Am J Respir Crit Care Med, 184, pp.957~963 (2011)
18. Natalini JG, "The dynamic lung microbiome in health and disease", Nat Rev Microbiol, 21, pp.222~235 (2023)
19. Hou K, "Microbiota in health and diseases", Signal Transduct Target Ther, 7, pp.135~ (2022)
20. Louveau A, "Revisiting the mechanisms of CNS immune privilege", Trends Immunol, 36, pp.569~577 (2015)
21. Ardain A, "Tissue-resident innate immunity in the lung", Immunology, 159, pp.245~256 (2020)
22. Kim YM, "Airway G-CSF identifies neutrophilic inflammation and contributes to asthma progression", Eur Respir J, 55, pp.1900827~ (2020)
23. Dantzer R, "From inflammation to sickness and depression : when the immune system subjugates the brain", Nat Rev Neurosci, 9, pp.46~56 (2008)
24. Cheng W, "Higher systemic immune-inflammation index and systemic inflammation response index levels are associated with stroke prevalence in the asthmatic population : a cross-sectional analysis of the NHANES 1999-2018", Front Immunol, 14, pp.1191130~ (2023)
25. Sonneville R, "Understanding brain dysfunction in sepsis", Ann Intensive Care, 3, pp.15~ (2013)
26. Torres A, "Pneumonia", Nat Rev Dis Primers, 7, pp.25~ (2021)
27. Shah FA, "Bidirectional relationship between cognitive function and pneumonia", Am J Respir Crit Care Med, 188, pp.586~592 (2013)
28. Chu CS, "Bacterial pneumonia and subsequent dementia risk : a nationwide cohort study", Brain Behav Immun, 103, pp.12~18 (2022)
29. Huang M, "Pathophysiology of brain injury and neurological outcome in acute respiratory distress syndrome : a scoping review of preclinical to clinical studies", Neurocrit Care, 35, pp.518~527 (2021)
30. Girard TD, "Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment : a prospective cohort study", Lancet Respir Med, 6, pp.213~222 (2018)
31. Irani F, "Is asthma associated with cognitive impairments? A meta-analytic review", J Clin Exp Neuropsychol, 39, pp.965~978 (2017)
32. Nair AK, "Asthma amplifies dementia risk : evidence from CSF biomarkers and cognitive decline", Alzheimers Dement(N Y), 8, pp.e12315~ (2022)
33. Nair AK, "Impact of asthma on the brain : evidence from diffusion MRI, CSF biomarkers and cognitive decline", Brain Commun, 5, pp.fcad180~ (2023)
34. Ren M, "Allergic asthma-induced cognitive impairment is alleviated by dexamethasone", Front Pharmacol, 12, pp.680815~ (2021)
35. Stoll P, "Stage-dependent association of BDNF and TGF-β1 with lung function in stable COPD", Respir Res, 13, pp.116~ (2012)
36. Lahiri DK, "Are pulmonary fibrosis and Alzheimer’s disease linked? Shared dysregulation of two miRNA species and downstream pathways accompany both disorders", J Biol Chem, 292, pp.20353~ (2017)
37. White J, "Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension", Respir Res, 7, pp.55~ (2006)
38. Bussotti M, "Anxiety and depression in patients with pulmonary hypertension : impact and management challenges", Vasc Health Risk Manag, 14, pp.349~360 (2018)
39. D’Orléans-Juste P, "Endothelins in inflammatory neurological diseases", Pharmacol Ther, 194, pp.145~160 (2019)
40. Mendiola AS, "The IL-1β phenomena in neuroinflammatory diseases", J Neural Transm(Vienna), 125, pp.781~795 (2018)
41. Correction to, "Temporal profile of pneumonia after stroke", Stroke, 53, pp.e129~ (2022)
42. Ghandour RM, "Prevalence and treatment of depression, anxiety, and conduct problems in us children", J Pediatr, 206, pp.256~267 (2019)
43. Wang T, "Asthma’s effect on brain connectivity and cognitive decline", Front Neurol, 13, pp.1065942~ (2023)
44. Fabisiak T, "Crosstalk between neuroinflammation and oxidative stress in epilepsy", Front Cell Dev Biol, 10, pp.976953~ (2022)
45. Chiang KL, "Association of epilepsy and asthma : a population-based retrospective cohort study", PeerJ, 6, pp.e4792~ (2018)
46. Li J, "The evaluation of cognitive impairment and relevant factors in patients with chronic obstructive pulmonary disease", Respiration, 85, pp.98~105 (2013)
47. Torres-Sánchez I, "Cognitive impairment in COPD : a systematic review", J Bras Pneumol, 41, pp.182~190 (2015)
48. Li CH, "The association between chronic obstructive pulmonary disease and Parkinson’s disease : a nationwide population-based retrospective cohort study", QJM, 108, pp.39~45 (2015)
49. Ranzini L, "From mild cognitive impairment(MCI)to dementia in chronic obstructive pulmonary disease. Implications for clinical practice and disease management : a mini-review", Front Psychol, 11, pp.337~ (2020)
50. Xiao T, "Lung function impairment and the risk of incident dementia : the Rotterdam study", J Alzheimers Dis, 82, pp.621~630 (2021)
51. Hambali A, "Hypoxia-induced neuroinflammation in Alzheimer’s disease : potential neuroprotective effects of Centella asiatica", Front Physiol, 12, pp.712317~ (2021)
52. Shi H, "Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke", Curr Med Chem, 16, pp.4593~4600 (2009)
53. Aliberti S, "Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia", Aging Clin Exp Res, 27, pp.523~531 (2015)
54. Xu W, "The implication of oxidative stress and ampk-nrf2 antioxidative signaling in pneumonia pathogenesis", Front Endocrinol(Lausanne), 11, pp.400~ (2020)
55. Feldman C, "Meningococcal pneumonia : a review", Pneumonia, 11, pp.3~ (2019)
56. Viegas CA, "Prevalence of risk factors for obstructive sleep apnea syndrome in interstate bus drivers", J Bras Pneumol, 32, pp.144~149 (2006)
57. Liu Z, "Association between inflammatory biomarkers and acute respiratory distress syndrome or acute lung injury risk : A systematic review and meta-analysis", Wien Klin Wochenschr, 134, pp.24~38 (2022)
58. Taghavi S, "Interleukin-22 mitigates acute respiratory distress syndrome(ARDS)", PLoS One, 16, pp.e0254985~ (2021)
59. Adhikari NK, "Self-reported symptoms of depression and memory dysfunction in survivors of ARDS", Chest, 135, pp.678~687 (2009)
60. Ziaka M, "ARDS associated acute brain injury : from the lung to the brain", Eur J Med Res, 27, pp.150~ (2022)
61. Jaecklin T, "Do soluble mediators cause ventilator-induced lung injury and multi-organ failure?", Intensive Care Med, 36, pp.750~757 (2010)
62. Robba C, "Ards and neurological outcome : there is not just one organ to protect!", Neurocrit Care, 35, pp.297~298 (2021)
63. Tsagkaris C, "Cytokine storm and neuropathological alterations in patients with neurological manifestations of COVID-19", Curr Alzheimer Res, 19, pp.641~657 (2022)
64. Corlateanu A, "Asthma and stroke : a narrative review", Asthma Res Pract, 7, pp.3~ (2021)
65. Austin V, "COPD and stroke : are systemic inflammation and oxidative stress the missing links?", Clin Sci(Lond), 130, pp.1039~1050 (2016)
66. Didier N, "Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability", J Neurochem, 86, pp.246~254 (2003)
67. Cifuentes D, "Hypertension accelerates the progression of Alzheimer-like pathology in a mouse model of the disease", Hypertension, 65, pp.218~224 (2015)
68. Shah TG, "The association between pulmonary hypertension and stroke : a systematic review and meta-analysis", Int J Cardiol, 295, pp.21~24 (2019)
69. Ho CH, "Impact of grouping complications on mortality in traumatic brain injury : a nationwide population-based study", PLoS One, 13, pp.e0190683~ (2018)
70. Zygun DA, "Ventilator-associated pneumonia in severe traumatic brain injury", Neurocrit Care, 5, pp.108~114 (2006)
71. Balczon R, "Pneumonia initiates a tauopathy", FASEB J, 35, pp.e21807~ (2021)
72. Scott AM, "Pneumonia-induced endothelial amyloids reduce dendritic spine density in brain neurons", Sci Rep, 10, pp.9327~ (2020)
73. Villalba N, "Lung infection by Pseudomonas aeruginosa induces neuroinflammation and blood-brain barrier dysfunction in mice", J Neuroinflammation, 20, pp.127~ (2023)
74. Rodríguez-Lucas C, "Pseudomonas aeruginosa nosocomial meningitis in neurosurgical patients with intraventricular catheters : therapeutic approach and review of the literature", Enferm Infecc Microbiol Clin(Engl Ed), 38, pp.54~58 (2020)
75. Ma Q, "Neurological disorders after severe pneumonia are associated with translocation of endogenous bacteria from the lung to the brain", Sci Adv, 9, pp.eadi0699~ (2023)
76. Diamond M, "Acute Respiratory Distress Syndrome" (2023), StatPearls Publishing
77. Matthay MA, "Acute respiratory distress syndrome", Nat Rev Dis Primers, 5, pp.18~ (2019)
78. Herridge MS, "Recovery and outcomes after the acute respiratory distress syndrome(ARDS)in patients and their family caregivers", Intensive Care Med, 42, pp.725~738 (2016)
79. Wilcox ME, "Cognitive dysfunction in ICU patients : risk factors, predictors, and rehabilitation interventions", Crit Care Med, 41, pp.S81~ (2013)
80. Kapfhammer HP, "Posttraumatic stress disorder and health-related quality of life in long-term survivors of acute respiratory distress syndrome", Am J Psychiatry, 161, pp.45~52 (2004)
81. Mikkelsen ME, "Cognitive, mood and quality of life impairments in a select population of ARDS survivors", Respirology, 14, pp.76~82 (2009)
82. Herridge MS, "Functional disability 5 years after acute respiratory distress syndrome", N Engl J Med, 364, pp.1293~1304 (2011)
83. Mart MF, "The long-lasting effects of the acute respiratory distress syndrome", Expert Rev Respir Med, 14, pp.577~586 (2020)
84. Hopkins RO, "Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome", Am J Respir Crit Care Med, 160, pp.50~56 (1999)
85. Bienvenu OJ, "Psychiatric symptoms after acute respiratory distress syndrome : a 5-year longitudinal study", Intensive Care Med, 44, pp.38~47 (2018)
86. Hsieh SJ, "The association between acute respiratory distress syndrome, delirium, and in-hospital mortality in intensive care unit patients", Am J Respir Crit Care Med, 191, pp.71~78 (2015)
87. Dolinay T, "Inflammasome-regulated cytokines are critical mediators of acute lung injury", Am J Respir Crit Care Med, 185, pp.1225~1234 (2012)
88. Ye L, "IL-1β and TNF-α induce neurotoxicity through glutamate production : a potential role for neuronal glutaminase", J Neurochem, 125, pp.897~908 (2013)
89. Lampl Y, "Minocycline treatment in acute stroke : an open-label, evaluator-blinded study", Neurology, 69, pp.1404~1410 (2007)
90. Zabad RK, "The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes : a pilot study", Mult Scler, 13, pp.517~526 (2007)
91. NINDS NET-PD Investigators, "A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease", Neurology, 66, pp.664~671 (2006)
92. Peukert K, "Inhibition of caspase-1 with tetracycline ameliorates acute lung injury", Am J Respir Crit Care Med, 204, pp.53~63 (2021)
93. Fries M, "S-100 protein and neurohistopathologic changes in a porcine model of acute lung injury", Anesthesiology, 102, pp.761~767 (2005)
94. Bickenbach J, "Neurological outcome after experimental lung injury", Respir Physiol Neurobiol, 179, pp.174~180 (2011)
95. Song P, "Global, regional, and national prevalence of asthma in 2019 : a systematic analysis and modelling study", J Glob Health, 12, pp.04052~ (2022)
96. Chabra R, "Allergic and Environmentally Induced Asthma" (2023), StatPearls Publishing
97. Sánchez-Borges M, "International consensus(ICON)on : clinical consequences of mite hypersensitivity, a global problem", World Allergy Organ J, 10, pp.14~ (2017)
98. Huang HJ, "House dust mite allergy : the importance of house dust mite allergens for diagnosis and immunotherapy", Mol Immunol, 158, pp.54~67 (2023)
99. Kanaya A, "Chronic allergic lung inflammation negatively influences neurobehavioral outcomes in mice", J Neuroinflammation, 19, pp.210~ (2022)
100. Johnson DB, "Dexamethasone" (2023), StatPearls Publishing
101. Bathina S, "Brain-derived neurotrophic factor and its clinical implications", Arch Med Sci, 11, pp.1164~1178 (2015)
102. Miranda M, "Brain-derived neurotrophic factor : a key molecule for memory in the healthy and the pathological brain", Front Cell Neurosci, 13, pp.363~ (2019)
103. Janicijevic SM, "Interplay of brain-derived neurotrophic factor and cytokines in schizophrenia", Exp Appl Biomed Res, 21, pp.283~289 (2020)
104. Wang S, "Secreted brain-derived neurotrophic factor and asthma severity", Am J Respir Cell Mol Biol, 54, pp.297~ (2016)
105. Sreter KB, "Plasma brain-derived neurotrophic factor(BDNF)concentration and BDNF", TRKB gene polymorphisms in Croatian adults with asthma, 2020, pp.10, 189~
106. Britt RD Jr, "Smooth muscle brain-derived neurotrophic factor contributes to airway hyperreactivity in a mouse model of allergic asthma", FASEB J, 33, pp.3024~3034 (2019)
107. Hahn C, "Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation", J Allergy Clin Immunol, 117, pp.787~794 (2006)
108. Singh D, "Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease : The gold science committee report 2019", Eur Respir J, 53, pp.1900164~ (2019)
109. Qin W, "The relationship between chronic obstructive pulmonary disease and cerebral small vessel disease assessed by magnetic resonance imaging : a case-control study from a single center in Beijing, China", Med Sci Monit, 26, pp.e925703~ (2020)
110. Yin M, "Patterns of brain structural alteration in COPD with different levels of pulmonary function impairment and its association with cognitive deficits", BMC Pulm Med, 19, pp.203~ (2019)
111. Liu CC, "Apolipoprotein E and Alzheimer disease : risk, mechanisms and therapy", Nat Rev Neurol, 9, pp.106~118 (2013)
112. Koutsodendris N, "Neuronal ApoE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits", Nat Aging, 3, pp.275~296 (2023)
113. Rusanen M, "Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer’s disease : a population-based cardiovascular risk factors, aging and dementia study", Dement Geriatr Cogn Disord, 30, pp.277~284 (2010)
114. Tjärnlund-Wolf A, "Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases", Stroke, 43, pp.2833~2839 (2012)
115. Donaldson GC, "Increased risk of myocardial infarction and stroke following exacerbation of COPD", Chest, 137, pp.1091~1097 (2010)
116. Waschki B, "Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function", Int J Chron Obstruct Pulmon Dis, 12, pp.981~987 (2017)
117. Todd NW, "Molecular and cellular mechanisms of pulmonary fibrosis", Fibrogenesis Tissue Repair, 5, pp.11~ (2012)
118. Ma H, "Targeting growth factor and cytokine pathways to treat idiopathic pulmonary fibrosis", Front Pharmacol, 13, pp.918771~ (2022)
119. Piersma B, "Signaling in fibrosis : TGF-β, WNT, and YAP", TAZ converge, 2015, pp.2, 59~
120. Zhao M, "Targeting fibrosis, mechanisms and cilinical trials", Signal Transduct Target Ther, 7, pp.206~ (2022)
121. Shill H, "Respiratory complications of Parkinson’s disease", Semin Respir Crit Care Med, 23, pp.261~265 (2002)
122. Bors M, "Cognitive function in idiopathic pulmonary fibrosis", Chron Respir Dis, 12, pp.365~372 (2015)
123. Mohammadi-Nejad AR, "Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk", EBioMedicine, 86, pp.104356~ (2022)
124. Jamialahmadi H, "Targeting transforming growth factor beta(TGF-β)using Pirfenidone, a potential repurposing therapeutic strategy in colorectal cancer", Sci Rep, 13, pp.14357~ (2023)
125. Bozkurt I, "Effects of pirfenidone on experimental head injury in rats", Int J Clin Exp Pathol, 15, pp.20~28 (2022)
126. von Bernhardi R, "Role of TGFβ signaling in the pathogenesis of Alzheimer’s disease", Front Cell Neurosci, 9, pp.426~ (2015)
127. Wyss-Coray T, "TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice", Nat Med, 7, pp.612~618 (2001)
128. Hu Y, "Wnt signalling in lung physiology and pathology", Handb Exp Pharmacol, 269, pp.305~336 (2021)
129. Königshoff M, "Functional Wnt signaling is increased in idiopathic pulmonary fibrosis", PLoS One, 3, pp.e2142~ (2008)
130. Martin-Medina A, "Increased extracellular vesicles mediate WNT5A signaling in idiopathic pulmonary fibrosis", Am J Respir Crit Care Med, 198, pp.1527~1538 (2018)
131. Serafino A, "Targeting the Wnt", β-catenin pathway in neurodegenerative diseases : recent approaches and current challenges, 2020, pp.15, 803~822
132. Wang Q, "Activation of Wnt", β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer’s disease, 2022, pp.145, 4474~4488
133. Thenappan T, "Pulmonary arterial hypertension : pathogenesis and clinical management", BMJ, 360, pp.j5492~ (2018)
134. Humbert M, "2022 ESC", ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2022, pp.43, 3618~3731
135. Roy B, "Brain structural changes in patients with pulmonary arterial hypertension", J Neuroimaging, 31, pp.524~531 (2021)
136. Malenfant S, "Compromised cerebrovascular regulation and cerebral oxygenation in pulmonary arterial hypertension", J Am Heart Assoc, 6, pp.e006126~ (2017)
137. Adir Y, "Sleep-related breathing disorders and pulmonary hypertension", Eur Respir J, 57, pp.2002258~ (2021)
138. Giaid A, "Expression of endothelin-1 in the lungs of patients with pulmonary hypertension", N Engl J Med, 328, pp.1732~1739 (1993)
139. Shao D, "The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension", Pharmacol Res, 63, pp.504~511 (2011)
140. Chester AH, "The role of endothelin-1 in pulmonary arterial hypertension", Glob Cardiol Sci Pract, 2014, pp.62~78 (2014)
141. Rubin LJ, "Bosentan therapy for pulmonary arterial hypertension", N Engl J Med, 346, pp.896~903 (2002)
142. Sarji S, "Pulmonary hypertension is associated with white matter and microvascular changes in the brain", Am J Respir Crit Care Med, 195, pp.A4201~ (2017)
143. Sharma RK, "Involvement of neuroinflammation in the pathogenesis of monocrotaline-induced pulmonary hypertension", Hypertension, 71, pp.1156~1163 (2018)
144. Ursell LK, "Defining the human microbiome", Nutr Rev, 70(Suppl 1), pp.S38~S44 (2012)
145. Gebrayel P, "Microbiota medicine : towards clinical revolution", J Transl Med, 20, pp.111~ (2022)
146. Zhu M, "Gut microbiota : a novel therapeutic target for Parkinson’s disease", Front Immunol, 13, pp.937555~ (2022)
147. Thirion F, "The gut microbiota in multiple sclerosis varies with disease activity", Genome Med, 15, pp.1~ (2023)
148. Taniya MA, "Role of gut microbiome in autism spectrum disorder and its therapeutic regulation", Front Cell Infect Microbiol, 12, pp.915701~ (2022)
149. Fan Y, "Gut microbiota in human metabolic health and disease", Nat Rev Microbiol, 19, pp.55~71 (2021)
150. Dickson RP, "The microbiome and the respiratory tract", Annu Rev Physiol, 78, pp.481~504 (2016)
151. Yildiz S, "Respiratory tissue-associated commensal bacteria offer therapeutic potential against pneumococcal colonization", eLife, 9, pp.e53581~ (2020)
152. Zhang D, "The cross-talk between gut microbiota and lungs in common lung diseases", Front Microbiol, 11, pp.301~ (2020)
153. Yang D, "The impact of lung microbiota dysbiosis on inflammation", Immunology, 159, pp.156~166 (2020)
154. Yang D, "Dysregulated lung commensal bacteria drive interleukin-17B production to promote pulmonary fibrosis through their outer membrane vesicles", Immunity, 50, pp.692~706 (2019)
155. Jin C, "Commensal microbiota promote lung cancer development via γδ t cells", Cell, 176, pp.998~1013 (2019)
156. Hosang L, "The lung microbiome regulates brain autoimmunity", Nature, 603, pp.138~144 (2022)
157. Hayer SS, "Antibiotic-induced gut dysbiosis and cognitive, emotional, and behavioral changes in rodents : a systematic review and meta-analysis", Front Neurosci, 17, pp.1237177~ (2023)
158. Sparks Stein P, "Serum antibodies to periodontal pathogens are a risk factor for Alzheimer’s disease", Alzheimers Dement, 8, pp.196~203 (2012)
159. Vogt NM, "Gut microbiome alterations in Alzheimer’s disease", Sci Rep, 7, pp.13537~ (2017)
160. Cattaneo A, "Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly", Neurobiol Aging, 49, pp.60~68 (2017)
161. Sikkema L, "An integrated cell atlas of the lung in health and disease", Nat Med, 29, pp.1563~1577 (2023)
162. Elmentaite R, "Cells of the human intestinal tract mapped across space and time", Nature, 597, pp.250~255 (2021)
163. Melo-González F, "Distal consequences of mucosal infections in intestinal and lung inflammation", Front Immunol, 13, pp.877533~ (2022)
164. Bery AI, "Role of tertiary lymphoid organs in the regulation of immune responses in the periphery", Cell Mol Life Sci, 79, pp.359~ (2022)
165. Bertrand Y, "IgA-producing B cells in lung homeostasis and disease", Front Immunol, 14, pp.1117749~ (2023)
166. Allie SR, "Resident memory B cells", Viral Immunol, 33, pp.282~293 (2020)
167. Xie L, "Analysis of lung microbiome in COVID-19 patients during time of hospitalization", Pathogens, 12, pp.944~ (2023)
168. Karvela A, "Lung microbiome : an emerging player in lung cancer pathogenesis and progression", Clin Transl Oncol, 25, pp.2365~2372 (2023)
169. Li R, "Lung microbiome : new insights into the pathogenesis of respiratory diseases", Signal Transduct Target Ther, 9, pp.19~ (2024)
170. Strandwitz P, "GABA-modulating bacteria of the human gut microbiota", Nat Microbiol, 4, pp.396~403 (2019)
171. Wu C, "GABA receptors in brain development, function, and injury", Metab Brain Dis, 30, pp.367~379 (2015)
172. Guyenet PG, "Regulation of breathing and autonomic outflows by chemoreceptors", Compr Physiol, 4, pp.1511~1562 (2014)
173. Frazier DT, "Role of phrenic nerve afferents in the control of breathing", J Appl Physiol, 70, pp.491~496 (1991)
174. Pacia EB, "Assessment of diaphragm function", Chest Surg Clin N Am, 8, pp.225~236 (1998)
175. Guyenet PG, "Neural structures that mediate sympathoexcitation during hypoxia", Respir Physiol, 121, pp.147~162 (2000)
176. Bongianni F, "Reciprocal connections between rostral ventrolateral medulla and inspiration-related medullary areas in the cat", Brain Res, 565, pp.171~174 (1991)
177. Chacón-Aponte AA, "Brain-lung interaction : a vicious cycle in traumatic brain injury", Acute Crit Care, 37, pp.35~44 (2022)
178. Crotty Alexander LE, "Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function", J Mol Med(Berl), 91, pp.637~644 (2013)
179. Chang MC, "The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis", Sci Rep, 10, pp.14759~ (2020)
180. Enaud R, "The gut-lung axis in health and respiratory diseases : A place for inter-organ and inter-kingdom crosstalks", Front Cell Infect Microbiol, 10, pp.9~ (2020)
181. Carabotti M, "The gut-brain axis : interactions between enteric microbiota, central and enteric nervous systems", Ann Gastroenterol, 28, pp.203~209 (2015)
182. Engevik MA, "Microbial metabolic capacity for intestinal folate production and modulation of host folate receptors", Front Microbiol, 10, pp.2305~ (2019)
183. Mazumder MH, "Lung-gut axis of microbiome alterations following co-exposure to ultrafine carbon black and ozone", Part Fibre Toxicol, 20, pp.15~ (2023)
184. Sencio V, "The lung-gut axis during viral respiratory infections : the impact of gut dysbiosis on secondary disease outcomes", Mucosal Immunol, 14, pp.296~304 (2021)

관련 논문AI추천